Mitochondria as targets for cancer chemotherapy

Seminars in Cancer Biology

Volumn 19, Issue 1, 2009, Pages 57-66

  Gogvadze, Vladimir ^a   Orrenius, Sten ^a   Zhivotovsky, Boris ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell death; Mitochondria; Therapy; Tumor; Warburg effect

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; 3 METHYLADENINE; 4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ANTIMYCIN A1; ANTINEOPLASTIC AGENT; ARSENIC ACID DERIVATIVE; ARSENIC TRIOXIDE; CAMPTOTHECIN; CISPLATIN; DIGITOXIN; DOXORUBICIN; ETOPOSIDE; GX15 003; INOSTAMYCIN; MITOMYCIN C; OBATOCLAX; UNCLASSIFIED DRUG; VINBLASTINE; ZINOSTATIN;

ANTINEOPLASTIC ACTIVITY; AUTOPHAGY; BINDING AFFINITY; CANCER CELL; CANCER CHEMOTHERAPY; CELL ACTIVITY; CELL DEATH; CELL KILLING; DRUG SYNTHESIS; GLYCOLYSIS; HUMAN; MITOCHONDRION; NONHUMAN; REVIEW; TUMOR RESISTANCE;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTOPHAGY; CALCIUM; CELL DEATH; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 60249089837     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2008.11.007     Document Type: Review

References (112)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
2. Warburg O. Über den Stoffwechsel der Tumoren (1930), Springer, Berlin Translated: The metabolism of tumors. Lindon: Arnold Constable
3. Simonnet H., Alazard N., Pfeiffer K., Gallou C., Beroud C., Demont J., et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23 (2002) 759-768
4. Nakashima R.A., Paggi M.G., and Pedersen P.L. Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells. Cancer Res 44 (1984) 5702-5706
5. Weinhouse S. The Warburg hypothesis fifty years later. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 87 (1976) 115-126
6. Hammond E.M., and Giaccia A.J. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331 (2005) 718-725
7. Moll U.M. Schramm LM. p53--an acrobat in tumorigenesis. Crit Rev Oral Biol Med 9 (1998) 23-37
8. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90 (1993) 4304-4308
9. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3 (2006) 177-185
10. Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271 (1996) 32529-32537
11. Wang T., Marquardt C., and Foker J. Aerobic glycolysis during lymphocyte proliferation. Nature 261 (1976) 702-705
12. Ibsen K.H. The Crabtree effect: a review. Cancer Res 21 (1961) 829-841
13. Guppy M., Greiner E., and Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 212 (1993) 95-99
14. Wojtczak L., Teplova V.V., Bogucka K., Czyz A., Makowska A., Wieckowski M.R., et al. Effect of glucose and deoxyglucose on the redistribution of calcium in ehrlich ascites tumour and Zajdela hepatoma cells and its consequences for mitochondrial energetics. Further arguments for the role of Ca(2+) in the mechanism of the crabtree effect. Eur J Biochem 263 (1999) 495-501
15. Lopez-Rios F., Sanchez-Arago M., Garcia-Garcia E., Ortega A.D., Berrendero J.R., Pozo-Rodriguez F., et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res 67 (2007) 9013-9017
16. Pelicano H., Carney D., and Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7 (2004) 97-110
17. Storz P. Reactive oxygen species in tumor progression. Front Biosci 10 (2005) 1881-1896
18. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20 (1998) 291-293
19. Guzy R.D., and Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91 (2006) 807-819
20. Brand M.D., Affourtit C., Esteves T.C., Green K., Lambert A.J., Miwa S., et al. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 37 (2004) 755-767
21. Derdak Z., Mark N.M., Beldi G., Robson S.C., Wands J.R., and Baffy G. The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res 68 (2008) 2813-2819
22. Fang J., Nakamura H., and Iyer A.K. Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 15 (2007) 475-486
23. Kong Q., and Lillehei K.O. Antioxidant inhibitors for cancer therapy. Med Hypotheses 51 (1998) 405-409
24. Huang P., Feng L., Oldham E.A., Keating M.J., and Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407 (2000) 390-395
25. Engel R.H., and Evens A.M. Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front Biosci 11 (2006) 300-312
26. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
27. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4 (2003) 552-565
28. Proskuryakov S.Y., Konoplyannikov A.G., and Gabai V.L. Necrosis: a specific form of programmed cell death?. Exp Cell Res 283 (2003) 1-16
29. Kitanaka C., and Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 6 (1999) 508-515
30. Morgan M.J., Kim Y.S., and Liu Z.G. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 18 (2008) 343-349
31. Boujrad H., Gubkina O., Robert N., Krantic S., and Susin S.A. AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle 6 (2007) 2612-2619
32. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (2004) 2891-2906
33. Lemasters J.J., Qian T., He L., Kim J.S., Elmore S.P., Cascio W.E., et al. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 4 (2002) 769-781
34. Moretti L., Yang E.S., Kim K.W., and Lu B. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist Updat 10 (2007) 135-143
35. Hippert M.M., O'Toole P.S., and Thorburn A. Autophagy in cancer: good, bad, or both?. Cancer Res 66 (2006) 9349-9351
36. Karantza-Wadsworth V., Patel S., Kravchuk O., Chen G., Mathew R., Jin S., et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21 (2007) 1621-1635
37. Mathew R., Karantza-Wadsworth V., and White E. Role of autophagy in cancer. Nat Rev Cancer 7 (2007) 961-967
38. Kim K.W., Hwang M., Moretti L., Jaboin J.J., Cha Y.I., and Lu B. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4 (2008) 659-668
39. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6 (2004) 1221-1228
40. Scherz-Shouval R., Shvets E., Fass E., Shorer H., Gil L., and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26 (2007) 1749-1760
41. Bras M., Queenan B., and Susin S.A. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 70 (2005) 231-239
42. Tsujimoto Y., Ikegaki N., and Croce C.M. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 2 (1987) 3-7
43. Tsujimoto Y., and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett 466 (2000) 6-10
44. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
45. Hennet T., Bertoni G., Richter C., and Peterhans E. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res 53 (1993) 1456-1460
46. Festjens N., van Gurp M., van Loo G., Saelens X., and Vandenabeele P. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol 111 (2004) 7-27
47. Cory S., Huang D.C., and Adams J.M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22 (2003) 8590-8607
48. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
49. Abel F., Sjoberg R.M., Nilsson S., Kogner P., and Martinsson T. Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology. Eur J Cancer 41 (2005) 635-646
50. Hunter D.R., and Haworth R.A. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195 (1979) 453-459
51. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (1999) 233-249
52. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529 (2000) 11-21
53. Leung A.W., and Halestrap A.P. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 1777 (2008) 946-952
54. Evtodienko Y.V., Teplova V.V., Azarashvily T.S., Kudin A., Prusakova O., Virtanen I., et al. The Ca2+ threshold for the mitochondrial permeability transition and the content of proteins related to Bcl-2 in rat liver and Zajdela hepatoma mitochondria. Mol Cell Biochem 194 (1999) 251-256
55. Kinnally K.W., and Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 12 (2007) 857-868
56. Pavlov E.V., Priault M., Pietkiewicz D., Cheng E.H., Antonsson B., Manon S., et al. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J Cell Biol 155 (2001) 725-731
57. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., and Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A 99 (2002) 1259-1263
58. Orrenius S., Gogvadze V., and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47 (2007) 143-183
59. Scatena R., Bottoni P., Pontoglio A., Mastrototaro L., and Giardina B. Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 17 (2008) 1533-1545
60. Halicka H.D., Ardelt B., Li X., Melamed M.M., and Darzynkiewicz Z. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res 55 (1995) 444-449
61. Geschwind J.F., Ko Y.H., Torbenson M.S., Magee C., and Pedersen P.L. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res 62 (2002) 3909-3913
62. Xu R.H., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65 (2005) 613-621
63. Cao X., Fang L., Gibbs S., Huang Y., Dai Z., Wen P., et al. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol 59 (2007) 495-505
64. Lopez-Lazaro M. Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved. Expert Opin Ther Targets 11 (2007) 1043-1053
65. Adams J.M., and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 (2007) 1324-1337
66. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17 (2005) 393-403
67. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
68. Huang S., and Sinicrope F.A. BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells. Cancer Res 68 (2008) 2944-2951
69. Kang M.H., Kang Y.H., Szymanska B., Wilczynska-Kalak U., Sheard M.A., Harned T.M., et al. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 110 (2007) 2057-2066
70. Kuroda J., Kimura S., Andreeff M., Ashihara E., Kamitsuji Y., Yokota A., et al. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms. Br J Haematol 140 (2008) 181-190
71. Vogler M., Dinsdale D., Sun X.M., Young K.W., Butterworth M., Nicotera P., et al. A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells. Cell Death Differ 15 (2008) 820-830
72. Gogvadze V., Robertson J.D., Zhivotovsky B., and Orrenius S. Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax. J Biol Chem 276 (2001) 19066-19071
73. Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ. 2008 Sep 19. [Epub ahead of print] PMID: 18806758.
74. Ponassi R., Biasotti B., Tomati V., Bruno S., Poggi A., Malacarne D., et al. A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity. Cell Cycle 7 (2008) 3211-3224
75. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116 (2004) 527-540
76. Kolluri S.K., Zhu X., Zhou X., Lin B., Chen Y., Sun K., et al. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14 (2008) 285-298
77. Wang J.L., Liu D., Zhang Z.J., Shan S., Han X., Srinivasula S.M., et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci U S A 97 (2000) 7124-7129
78. Tzung S.P., Kim K.M., Basanez G., Giedt C.D., Simon J., Zimmerberg J., et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 3 (2001) 183-191
79. Campas C., Cosialls A.M., Barragan M., Iglesias-Serret D., Santidrian A.F., Coll-Mulet L., et al. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Exp Hematol 34 (2006) 1663-1669
80. Konopleva M., Watt J., Contractor R., Tsao T., Harris D., Estrov Z., et al. Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax). Cancer Res 68 (2008) 3413-3420
81. Larochette N., Decaudin D., Jacotot E., Brenner C., Marzo I., Susin S.A., et al. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res 249 (1999) 413-421
82. Nutt L.K., Gogvadze V., Uthaisang W., Mirnikjoo B., McConkey D.J., and Orrenius S. Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis. Cancer Biol Ther 4 (2005) 459-467
83. Robertson J.D., Gogvadze V., Zhivotovsky B., and Orrenius S. Distinct pathways for stimulation of cytochrome c release by etoposide. J Biol Chem 275 (2000) 32438-32443
84. Pastorino J.G., and Hoek J.B. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr 40 (2008) 171-182
85. Haridas V., Li X., Mizumachi T., Higuchi M., Lemeshko V.V., Colombini M., et al. Avicins, a novel plant-derived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane. Mitochondrion 7 (2007) 234-240
86. Abu-Hamad S., Zaid H., Israelson A., Nahon E., and Shoshan-Barmatz V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J Biol Chem 283 (2008) 13482-13490
87. Wolvetang E.J., Johnson K.L., Krauer K., Ralph S.J., and Linnane A.W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 339 (1994) 40-44
88. Asoh S., Mori T., Hayashi J., and Ohta S. Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria. J Biochem 120 (1996) 600-607
89. Xiao D., Powolny A.A., and Singh S.V. Benzyl Isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem 283 (2008) 30151-30163
90. Chen Y., McMillan-Ward E., Kong J., Israels S.J., and Gibson S.B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci 120 (2007) 4155-4166
91. Prasad K.N., and Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res 42 (1982) 550-555
92. Qian M., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. Nutr Cancer 25 (1996) 9-26
93. Neuzil J., Weber T., Gellert N., and Weber C. Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer 84 (2001) 87-89
94. Weber T., Lu M., Andera L., Lahm H., Gellert N., Fariss M.W., et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res 8 (2002) 863-869
95. Neuzil J., Dyason J.C., Freeman R., Dong L.F., Prochazka L., Wang X.F., et al. Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr 39 (2007) 65-72
96. Neuzil J., Wang X.F., Dong L.F., Low P., and Ralph S.J. Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett 580 (2006) 5125-5129
97. Yu W., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res 63 (2003) 2483-2491
98. Montero J., Morales A., Llacuna L., Lluis J.M., Terrones O., Basanez G., et al. Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res 68 (2008) 5246-5256
99. Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C., Thompson R., et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11 (2007) 37-51
100. Michelakis E.D., Webster L., and Mackey J.R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 99 (2008) 989-994
101. Schulz T.J., Thierbach R., Voigt A., Drewes G., Mietzner B., Steinberg P., et al. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol Chem 281 (2006) 977-981
102. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
103. Zhou S., Kachhap S., and Singh K.K. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 18 (2003) 287-292
104. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., et al. p53 regulates mitochondrial respiration. Science 312 (2006) 1650-1653
105. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126 (2006) 107-120
106. Tanaka H., Arakawa H., Yamaguchi T., Shiraishi K., Fukuda S., Matsui K., et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404 (2000) 42-49
107. Nutt L.K., Margolis S.S., Jensen M., Herman C.E., Dunphy W.G., Rathmell J.C., et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 123 (2005) 89-103
108. Marchenko N.D., Zaika A., and Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275 (2000) 16202-16212
109. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., et al. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 65 (2005) 3745-3750
110. Zache N., Lambert J.M., Wiman K.G., and Bykov V.J. PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53. Cell Oncol 30 (2008) 411-418
111. Shen J., Vakifahmetoglu H., Stridh H., Zhivotovsky B., and Wiman K.G. PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2. Oncogene 27 (2008) 6571-6580
112. Wang T., Lee K., Rehman A., and Daoud S.S. PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax. Biochem Biophys Res Commun 352 (2007) 203-212